中国药物经济学2025，Vol.20Issue(9)：12-17,6.DOI:10.12010/j.issn.1673-5846.2025.09.002
非酒精性脂肪性肝病临床管理的卫生经济学评价研究进展
Research Progress on Health Economics Evaluation of Clinical Management of Non-alcoholic Fatty Liver Disease
摘要
Abstract
Non-alcoholic fatty liver disease(NAFLD)is the most common chronic liver disease worldwide,with its incidence continuing to rise rapidly.It poses a serious threat to human health and places a significant economic burden on society.The research on health economics evaluation of clinical management of NAFLD started earlier in foreign countries,but China still in the initial stage.This article summarizes and analyzes the methods,evaluation models,and research directions in the health economics evaluation of NAFLD clinical management,aiming to provide high-quality evidence for the development of clinical management strategies for NAFLD in China.关键词
非酒精性脂肪性肝病/临床管理/卫生经济学评价/综述Key words
Non-alcoholic fatty liver disease/Clincial management/Health economic evaluation/Review分类
医药卫生引用本文复制引用
徐佳音,吕柯鑫,郝浩杰,费涵,权一丹,张伟..非酒精性脂肪性肝病临床管理的卫生经济学评价研究进展[J].中国药物经济学,2025,20(9):12-17,6.基金项目
浙江省卫健委医药卫生科技计划项目(2025KY136) （2025KY136）
杭州市卫健委卫生科技计划项目(A20240364) （A20240364）
